BioBanking - The Holy Grail of novel drug and diagnostic developments?
Open Access
- 1 January 2011
- journal article
- Published by ClinTransMed, AB in Journal of Clinical Bioinformatics
- Vol. 1 (1) , 14
Abstract
The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.Keywords
This publication has 2 references indexed in Scilit:
- Developments for a growing Japanese patient population: Facilitating new technologies for future health careJournal of Proteomics, 2011
- Proteomics, Human Proteome Project, and ChromosomesJournal of Proteome Research, 2011